Aarti Drugs

475.05
-15.85
(-3.23%)
Market Cap
4,335.78 Cr
EPS
18.35
PE Ratio
26.85
Dividend Yield
0.20 %
Industry
Healthcare
52 Week High
635.00
52 Week Low
312.00
PB Ratio
3.30
Debt to Equity
0.47
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold+100.00 %
+100.00 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,672.50
#1 4,01,288.77
35.18
#1 54,729.00
12.06
#1 10,980
-18.99
48.33
6,938.00
1,84,182.10
83.40
9,360.00
0.89
2,117
23.05
68.54
1,488.30
1,20,211.16
23.71
28,409.50
7.12
5,291
30.28
54.26
3,322.40
1,12,445.11
59.20
11,539.40
11.59
1,911
10.91
62.08
1,283.80
1,07,142.24
#1 19.71
33,741.20
12.36
5,725
21.14
54.13
2,431.70
1,00,363.25
50.14
12,207.40
19.57
1,925
-10.91
59.65
983.20
98,932.93
21.52
22,573.80
13.82
3,977
-0.19
69.99
1,922.10
87,781.44
27.52
22,192.10
#1 19.94
3,024
#1 112.49
53.08
34,160.00
72,587.62
51.77
6,409.15
10.80
1,417
27.83
64.97
1,147.70
66,658.60
19.91
31,378.10
17.55
3,366
-0.50
63.70
Forecast
Actual
Growth Rate
Revenue Growth
-6.83 %
Net Income Growth
3.12 %
Cash Flow Change
169.22 %
ROE
-4.01 %
ROCE
-6.00 %
EBITDA Margin (Avg.)
11.75 %

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,002
1,102
1,191
1,389
1,456
1,577
1,766
2,208
2,421
2,432
2,575
Fixed Assets
449
493
581
602
625
644
665
690
676
811
1,196
Current Assets
526
565
571
737
784
900
1,057
1,393
1,492
1,321
1,338
Capital Work in Progress
16
34
14
28
33
12
19
77
210
261
330
Investments
0
0
12
11
12
13
17
20
19
20
473
Other Assets
537
575
584
748
785
907
1,064
1,422
1,516
1,340
0
Total Liabilities
1,002
1,102
1,191
1,389
1,456
1,577
1,766
2,208
2,421
2,432
2,575
Current Liabilities
483
501
494
622
591
623
595
940
950
796
837
Non Current Liabilities
211
244
297
312
321
301
257
232
279
355
368
Total Equity
308
357
400
455
543
653
913
1,036
1,193
1,282
1,369
Reserve & Surplus
284
333
376
432
520
629
820
944
1,100
1,190
1,278
Share Capital
24
24
24
24
24
23
93
93
93
92
91

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
1
-0
0
1
2
2
13
-14
-1
Investing Activities
-107
-99
-107
-74
-62
-33
-72
-150
-164
-224
Operating Activities
105
133
175
70
143
251
155
70
133
359
Financing Activities
2
-33
-68
4
-80
-215
-81
92
17
-136

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
60.20 %
60.14 %
60.12 %
59.99 %
59.83 %
59.98 %
59.77 %
59.66 %
59.58 %
58.70 %
58.56 %
57.47 %
57.13 %
55.67 %
55.64 %
55.38 %
55.48 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.33 %
2.10 %
2.56 %
2.96 %
2.50 %
2.28 %
2.25 %
DIIs
1.59 %
1.97 %
2.09 %
2.28 %
2.69 %
2.76 %
3.16 %
3.90 %
4.09 %
4.71 %
5.32 %
5.26 %
5.99 %
7.35 %
7.84 %
8.77 %
9.70 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
31.86 %
32.32 %
32.68 %
32.85 %
32.02 %
32.16 %
26.66 %
25.98 %
25.72 %
25.34 %
24.65 %
25.84 %
25.11 %
24.75 %
24.80 %
24.32 %
23.51 %
Others
6.36 %
5.57 %
5.11 %
4.89 %
5.46 %
5.10 %
10.41 %
10.46 %
10.61 %
11.25 %
9.14 %
9.33 %
9.20 %
9.27 %
9.21 %
9.24 %
9.06 %
No of Share Holders
1,73,704
1,77,992
1,83,344
1,95,469
1,89,607
1,86,674
1,80,303
1,73,283
1,69,090
1,62,409
1,67,446
1,70,414
1,57,547
1,50,218
1,90,281
1,76,006
1,69,761

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1 1 1 2 2.5 1 1 1 0.00
Dividend Yield (%) 0.00 0.79 0.63 0.8 0.29 0.58 0.3 0.23 0.29 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
06 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 May 2025 351.35 349.75
04 Feb 2025 DIVIDEND Dividend
₹ 1.00 /share
04 Feb 2025 396.70 414.90
29 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Jan 2025 415.90 396.70
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 500.50 484.90
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 584.00 524.80
06 Feb 2024 DIVIDEND Dividend
₹ 1.00 /share
06 Feb 2024 535.25 538.65
08 Feb 2023 DIVIDEND Dividend
₹ 1.00 /share
08 Feb 2023 410.15 394.30
10 Feb 2022 DIVIDEND Dividend
₹ 1.00 /share
09 Feb 2022 503.60 525.45
01 Oct 2020 BONUS Bonus
3:1
30 Sept 2020 710.79 810.10

Announcements

Closure of Trading WindowJun 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 14, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 07, 2025
Disclosure Under Regulation 30 - Ad-Interim Order By The CourtMay 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 06, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 06, 2025
Board Meeting Outcome for Financial Results For The Quarter And Year Ended March 31 2025 And Appointment Of Cost AuditorMay 06, 2025
Outcome Of The Board Meeting And Financial Results For The Quarter And Year Ended March 31 2025May 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 29, 2025
Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended March 31 2025Apr 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Disclosure Under Regulation 30 Of SEBI Listing RegulationsApr 02, 2025
Closure of Trading WindowMar 29, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 11, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations")Mar 07, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") - Action Taken Or Order PassedMar 06, 2025
Announcement Under Regulation 30 Of Listing Regulations - ESG RatingMar 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Disclosure Under Reg 30 Of Listing Regulations - Update On Lifting Of Import Alert 66-40 By US DFAFeb 14, 2025
Disclosure Under Regulation 30 Of Listing Reguations- Order Of CGST And C.Ex. AuthorityFeb 07, 2025
Disclosure Under Regulation 30 Of Listing Regulations-Feb 05, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 04, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 04, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJan 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 29, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJan 29, 2025
Integrated Filing (Financial)Jan 29, 2025
Record Date For Interim DividendJan 29, 2025
Corporate Action-Board approves DividendJan 29, 2025
Board Meeting Outcome for Financial Results And Interim DividendJan 29, 2025
Financial Results For The Quarter And Nine Months Ended December 31 2024 And Interim DividendJan 29, 2025
Disclosure Under Regulation 30 Of Listing RegulationsJan 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 23, 2025
Board Meeting Intimation for Financial Results For The Quarter And Nine Months Ended December 31 2024 And Interim Dividend If Any.Jan 22, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJan 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Closure of Trading WindowDec 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 15, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 06, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 06, 2024

Technical Indicators

RSI(14)
Neutral
67.42
ATR(14)
Less Volatile
16.78
STOCH(9,6)
Overbought
82.59
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
3.49
ADX(14)
Strong Trend
32.70
UO(9)
Bearish
48.94
ROC(12)
Uptrend And Accelerating
11.63
WillR(14)
Overbought
-11.52

Mutual Fund Holdings